Ghassan K. Abou-Alfa, MD, highlights the potential role of immunotherapy in patients with liver cancer, remarking on key aspects of what patients can expect if they are eligible for treatment with an immunotherapy agent.
▼ Episode 1 Treatment Options for Liver Cancer
Ghassan K. Abou-Alfa, MD, discusses the challenges associated with treating liver cancer and highlights the various therapies used in the management of the disease.
► Episode 5 Future of Immunotherapy in Liver Cancer
Ghassan K. Abou-Alfa, MD, shares his excitement over the use of immunotherapy for liver cancer in 2018, and highlights research initiatives that are studying its potential in combination with other therapies.